English
Chief Physician, Professor, Doctor of Oncology (PH.D&MD), Doctoral Supervisor and Postdoctoral Supervisor of Tongji University. He is selected into the Shanghai Talent Development Program and the Outstanding Backbone Program of Shanghai Pulmonary Hospital, and a member of the Shanghai Outstanding Talent Pool. He leads a team that has long been engaged in basic and clinical research on lung cancer. His research directions cover tumor radiotherapy resistance, regulation of tumor immune microenvironment, radiation injury, artificial intelligence and precision radiotherapy, as well as nano drug delivery. He boasts rich clinical experience. He is invited to deliver academic reports annually at the World Conference on Lung Cancer, European Lung Cancer Conference and American Lung Cancer Conference. With advanced treatment concepts and remarkable therapeutic effects, he is widely recognized by peers at home and abroad. As a compassionate medical practitioner, he treats patients patiently and carefully.
He specializes in the early diagnosis of small pulmonary nodules, ground-glass opacities and lung cancer, as well as comprehensive treatments including radiotherapy, immunotherapy, targeted therapy and concurrent chemoradiotherapy for lung cancer.
